Literature DB >> 28152578

Phosphatase and tensin homolog-β-catenin signaling modulates regulatory T cells and inflammatory responses in mouse liver ischemia/reperfusion injury.

Qiang Zhu1,2,3,4, Changyong Li4,5, Kunpeng Wang1,2, Shi Yue6, Longfeng Jiang4, Michael Ke4, Ronald W Busuttil4, Jerzy W Kupiec-Weglinski4, Feng Zhang1,2, Ling Lu1,2, Bibo Ke4.   

Abstract

The phosphatase and tensin homolog (PTEN) deleted on chromosome 10 plays an important role in regulating T cell activation during inflammatory response. Activation of β-catenin is crucial for maintaining immune homeostasis. This study investigates the functional roles and molecular mechanisms by which PTEN-β-catenin signaling promotes regulatory T cell (Treg) induction in a mouse model of liver ischemia/reperfusion injury (IRI). We found that mice with myeloid-specific phosphatase and tensin homolog knockout (PTENM-KO ) exhibited reduced liver damage as evidenced by decreased levels of serum alanine aminotransferase, intrahepatic macrophage trafficking, and proinflammatory mediators compared with the PTEN-proficient (floxed phosphatase and tensin homolog [PTENFL/FL ]) controls. Disruption of myeloid PTEN-activated b-catenin promoted peroxisome proliferator-activated receptor gamma (PPARγ)-mediated Jagged-1/Notch signaling and induced forkhead box P3 (FOXP3)1 Tregs while inhibiting T helper 17 cells. However, blocking of Notch signaling by inhibiting γ-secretase reversed myeloid PTEN deficiency-mediated protection in ischemia/reperfusion-triggered liver inflammation with reduced FOXP3+ and increased retinoid A receptor-related orphan receptor gamma t-mediated interleukin 17A expression in ischemic livers. Moreover, knockdown of β-catenin or PPARγ in PTEN-deficient macrophages inhibited Jagged-1/Notch activation and reduced FOXP3+ Treg induction, leading to increased proinflammatory mediators in macrophage/T cell cocultures. In conclusion, our findings demonstrate that PTEN-β-catenin signaling is a novel regulator involved in modulating Treg development and provides a potential therapeutic target in liver IRI. Liver Transplantation 23 813-825 2017 AASLD.
© 2017 by the American Association for the Study of Liver Diseases.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28152578      PMCID: PMC5449221          DOI: 10.1002/lt.24735

Source DB:  PubMed          Journal:  Liver Transpl        ISSN: 1527-6465            Impact factor:   5.799


  38 in total

1.  Activation of beta-catenin in dendritic cells regulates immunity versus tolerance in the intestine.

Authors:  Santhakumar Manicassamy; Boris Reizis; Rajesh Ravindran; Helder Nakaya; Rosa Maria Salazar-Gonzalez; Yi-Chong Wang; Bali Pulendran
Journal:  Science       Date:  2010-08-13       Impact factor: 47.728

2.  Role of tumor necrosis factor-alpha in the pathophysiologic alterations after hepatic ischemia/reperfusion injury in the rat.

Authors:  L M Colletti; D G Remick; G D Burtch; S L Kunkel; R M Strieter; D A Campbell
Journal:  J Clin Invest       Date:  1990-06       Impact factor: 14.808

3.  Role of SMAD and non-SMAD signals in the development of Th17 and regulatory T cells.

Authors:  Ling Lu; Julie Wang; Feng Zhang; Yang Chai; David Brand; Xuehao Wang; David A Horwitz; Wei Shi; Song Guo Zheng
Journal:  J Immunol       Date:  2010-03-19       Impact factor: 5.422

4.  Myeloid PTEN deficiency protects livers from ischemia reperfusion injury by facilitating M2 macrophage differentiation.

Authors:  Shi Yue; Jianhua Rao; Jianjun Zhu; Ronald W Busuttil; Jerzy W Kupiec-Weglinski; Ling Lu; Xuehao Wang; Yuan Zhai
Journal:  J Immunol       Date:  2014-04-25       Impact factor: 5.422

5.  Neutrophil infiltration as an important factor in liver ischemia and reperfusion injury. Modulating effects of FK506 and cyclosporine.

Authors:  S Suzuki; L H Toledo-Pereyra; F J Rodriguez; D Cejalvo
Journal:  Transplantation       Date:  1993-06       Impact factor: 4.939

6.  The activation of Wnt signaling by a STAT6-dependent macrophage phenotype promotes mucosal repair in murine IBD.

Authors:  J Cosín-Roger; D Ortiz-Masiá; S Calatayud; C Hernández; J V Esplugues; M D Barrachina
Journal:  Mucosal Immunol       Date:  2015-11-25       Impact factor: 7.313

7.  Notch signaling regulates the FOXP3 promoter through RBP-J- and Hes1-dependent mechanisms.

Authors:  Hai-Feng Ou-Yang; Hong-Wei Zhang; Chang-Gui Wu; Ping Zhang; Jian Zhang; Jun-Chang Li; Li-Hong Hou; Fei He; Xin-Yu Ti; Li-Qiang Song; Su-Zhen Zhang; Lei Feng; Hao-Wen Qi; Hua Han
Journal:  Mol Cell Biochem       Date:  2008-09-06       Impact factor: 3.396

8.  Macrophage PTEN regulates expression and secretion of arginase I modulating innate and adaptive immune responses.

Authors:  Emine Sahin; Stefan Haubenwallner; Mario Kuttke; Isabella Kollmann; Angela Halfmann; Alexander M Dohnal; Alexander B Dohnal; Li Chen; Paul Cheng; Bastian Hoesel; Elisa Einwallner; Julia Brunner; Julia B Kral; Waltraud C Schrottmaier; Kathrin Thell; Victoria Saferding; Stephan Blüml; Gernot Schabbauer
Journal:  J Immunol       Date:  2014-07-11       Impact factor: 5.422

9.  Tumor suppressor PTEN inhibits nuclear accumulation of beta-catenin and T cell/lymphoid enhancer factor 1-mediated transcriptional activation.

Authors:  S Persad; A A Troussard; T R McPhee; D J Mulholland; S Dedhar
Journal:  J Cell Biol       Date:  2001-06-11       Impact factor: 10.539

10.  The transcriptional repressor Hes1 attenuates inflammation by regulating transcription elongation.

Authors:  Yingli Shang; Maddalena Coppo; Teng He; Fei Ning; Li Yu; Lan Kang; Bin Zhang; Chanyang Ju; Yu Qiao; Baohong Zhao; Manfred Gessler; Inez Rogatsky; Xiaoyu Hu
Journal:  Nat Immunol       Date:  2016-06-20       Impact factor: 25.606

View more
  8 in total

Review 1.  The functions of tumor suppressor PTEN in innate and adaptive immunity.

Authors:  Lang Chen; Deyin Guo
Journal:  Cell Mol Immunol       Date:  2017-06-26       Impact factor: 11.530

2.  The protective effect of PPARγ in sepsis-induced acute lung injury via inhibiting PTEN/β-catenin pathway.

Authors:  Lili Liu; Junyi Chen; Xiaofang Zhang; Xue Cui; Nana Qiao; Yun Zhang; Jie Yang
Journal:  Biosci Rep       Date:  2020-05-29       Impact factor: 3.840

3.  The Modulation of Regulatory T Cells via HMGB1/PTEN/β-Catenin Axis in LPS Induced Acute Lung Injury.

Authors:  Min Zhou; Haoshu Fang; Min Du; Changyong Li; Rui Tang; Haiyan Liu; Zhi Gao; Zongshu Ji; Bibo Ke; Xu-Lin Chen
Journal:  Front Immunol       Date:  2019-07-25       Impact factor: 7.561

4.  Myeloid Notch1 deficiency activates the RhoA/ROCK pathway and aggravates hepatocellular damage in mouse ischemic livers.

Authors:  Ling Lu; Shi Yue; Longfeng Jiang; Changyong Li; Qiang Zhu; Michael Ke; Hao Lu; Xuehao Wang; Ronald W Busuttil; Qi-Long Ying; Jerzy W Kupiec-Weglinski; Bibo Ke
Journal:  Hepatology       Date:  2018-01-24       Impact factor: 17.298

5.  A novel neuregulin - jagged1 paracrine loop in breast cancer transendothelial migration.

Authors:  Ramon M Cabrera; Serena P H Mao; Chinmay R Surve; John S Condeelis; Jeffrey E Segall
Journal:  Breast Cancer Res       Date:  2018-04-10       Impact factor: 6.466

6.  Loss of ATF3 exacerbates liver damage through the activation of mTOR/p70S6K/ HIF-1α signaling pathway in liver inflammatory injury.

Authors:  Qiang Zhu; Han Wang; Bin Jiang; Xuhao Ni; Longfeng Jiang; Changyong Li; Xuehao Wang; Feng Zhang; Bibo Ke; Ling Lu
Journal:  Cell Death Dis       Date:  2018-09-05       Impact factor: 8.469

7.  Defining fallopian tube-derived miRNA cancer signatures.

Authors:  Selam B Dejene; Anders W Ohman; Wei Du; Deepinder Randhawa; Anand Bradley; Niraj Yadav; Kevin M Elias; Daniela M Dinulescu; Sunita R Setlur
Journal:  Cancer Med       Date:  2019-09-10       Impact factor: 4.452

8.  YAP-Dependent Induction of CD47-Enriched Extracellular Vesicles Inhibits Dendritic Cell Activation and Ameliorates Hepatic Ischemia-Reperfusion Injury.

Authors:  Zenan Yuan; Linsen Ye; Xiao Feng; Tian Zhou; Yi Zhou; Shuguang Zhu; Changchang Jia; Haibo Li; Dongbo Qiu; Kun Li; Wei Liu; Yang Li; Hui Tang; Guoying Wang; Qi Zhang; Yang Yang; Guihua Chen; Hua Li
Journal:  Oxid Med Cell Longev       Date:  2021-06-22       Impact factor: 6.543

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.